Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis

ABSTRACT: Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis

PROVIDER: PRJNA522736 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis.

Project description: Not available

| S-EPMC6453981 | biostudies-literature

Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis

Project description:We isolated GFP-positive and negative cell populations, by fluorescence-activated cell sorting (FACS), from Tg(fli1a:EGFP)y1 embryos at 22-24 hpf, then extracted their RNAs for high-through put sequencing based on Illumina HiSeq2000 to find out enriched genes in vascular, hematopoietic and pharyngeal arch cells

2019-03-07 | GSE126617 | GEO

Mir-130a potentiates the reparative properties of human endothelial colony forming cells facing hypoxia via VEGFR2 and STAT3

Project description:Hypoxia controls reparative angiogenesis. MiRNAs are master regulators of gene expression in hypoxia and angiogenesis. However, we do not yet have a clear understanding of how hypoxia-induced miRNAs modulate vasoreparative processes. Here, we identify miR-130a as a mediator of the hypoxic response in human primary endothelial colony forming cells (ECFCs), a well-characterized subtype of endothelial progenitor. Under hypoxic conditions, miR-130a overexpression enhances ECFC pro-angiogenic capacity in vitro and potentiates their vasoreparative properties in vivo. Mechanistically, miR-130a orchestrates upregulation of VEGFR2, activation of STAT3-dependent transcription, and accumulation of HIF1α via translational inhibition of DDX6. These findings unveil a new role for miR-130a in hypoxia, whereby it modulates the VEGFR2/STAT3/HIF1α axis to increase the vasoregenerative capacity of ECFCs.

2022-12-06 | GSE142123 | GEO

VEGFR2

Project description:VEGFR2 Y949F mutation

| PRJEB44298 | ENA

Wnt-signaling potentiates nevogenesis.

Project description:Wnt-signaling potentiates nevogenesis.

| PRJNA202396 | ENA

Role of Y1212 VEGFR2 signaling transduction

Project description:The project concerns vascular endothelial growth factor (VEGF) signaling, which is dependent on binding of VEGF to VEGF receptor-2 (VEGFR2) and leads to activation of the receptor kinase and autophosphorylation. Previous mouse studies with the VEGFR-2 phosphorylation site mutation Y1212F showed reduced vascular stability. We here investigate with LC-MS proteomics which signal transduction pathway(s) are lost in the mutant by identifying proteins that bind to the Y1212F site.

2019-08-13 | PXD014517 | Pride

VEGFR2 Y949F (lung RNAseq - mice)

Project description:RNA sequencing of lung tissue from transgenic mice in order to investigate the effect of a single tyrosine to phenylalanine exchange in the endothelial receptor VEGFR2 at position Y949. This exchange creates a mouse with unleaky blood vessels which is an advantage in several diseases such as cancer and cardiovascular disease.

2020-06-12 | E-MTAB-9163 | biostudies-arrayexpress

VEGFR2 Y949F (lung RNAseq - mice)

Project description:VEGFR2 Y949F (lung RNAseq - mice)

| PRJEB38638 | ENA

VEGFR2 pY1173 binding partners as identified by shotgun proteomics

Project description:The main goal of the project was to identify proteins binding to vascular endothelial growth factor receptor 2 (VEGFR2) phosphorylation site Y1173. Synthetic peptides, phosphorylated or not, covering different tyrosine phosphorylation sites in VEGFR2 were immobilized and incubated with cell lysates from human umbilical vein endothelial cells. Retained proteins were analyzed by mass spectrometry. Proteins specifically binding to pY1173 peptide were categorized with regard to the presence of an Src Homology 2 (SH2) domain and the main hits were validated in intact cells treated or not with VEGF, for their ability to bind to the activated wild type VEGFR2 but not to a mutant Y1173F VEGFR2. The role of the pY1173 binding partners in VEGF-regulated endothelial biology was further examined in vitro and in vivo.

2023-09-19 | PXD041024 | Pride

Tumor-independent host gene expression changes induced by VEGFR2 antibody

Project description:Transcriptome analysis was used to identify tumor-independent changes after treatment with mouse VEGFR2 neutralizing antibody.

2018-03-29 | GSE112467 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data